Episode

Episode 157 - Harold Bernstein - President, R&D Maze Therapeutics

Podcast
The BioHub - by Avetix
Published
Apr 22, 2026
Duration seconds
1481
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-157---Harold-Bernstein---President--RD-Maze-Therapeutics-e3i7r99
Audio
https://anchor.fm/s/f0076084/podcast/play/118794985/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-21%2F422520788-44100-2-82ae918de9893.mp3
JSON
/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-157-harold-bernstein-president-r-d-maze-therapeutics
Markdown
/podcast/the-biohub-by-avetix-7252289/episode-157-harold-bernstein-president-r-d-maze-therapeutics.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-157-harold-bernstein-president-r-d-maze-therapeutics/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-157-harold-bernstein-president-r-d-maze-therapeutics.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of The BioHub Podcast , Max sits down with Harold Bernstein. Harold brings decades of experience across biotech and pharma, with a career spanning leadership roles, company building, and advancing innovative therapies through development. In this conversation, we explore Harold’s journey through the industry, the lessons he’s learned along the way, and his perspective on how biotech companies can successfully navigate today’s evolving landscape. We also discuss the science behind what he’s working on today, the challenges of building in biotech, and where the industry is heading next.